These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27388564)

  • 1. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
    Bellamkonda K; Chandrashekar NK; Osman J; Selvanesan BC; Savari S; Sjölander A
    BMC Cancer; 2016 Jul; 16():425. PubMed ID: 27388564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of inflammatory lipid mediators on colon cancer-initiating cells.
    Bellamkonda K; Sime W; Sjölander A
    Mol Carcinog; 2015 Nov; 54(11):1315-27. PubMed ID: 25154976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
    Vinnakota K; Zhang Y; Selvanesan BC; Topi G; Salim T; Sand-Dejmek J; Jönsson G; Sjölander A
    J Cell Physiol; 2017 Dec; 232(12):3468-3480. PubMed ID: 28098359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
    Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
    J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Osman J; Bellamkonda K; Liu Q; Andersson T; Sjölander A
    Anticancer Res; 2019 Apr; 39(4):1719-1728. PubMed ID: 30952711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammatory mediator leukotriene D₄ induces subcellular β-catenin translocation and migration of colon cancer cells.
    Salim T; Sand-Dejmek J; Sjölander A
    Exp Cell Res; 2014 Feb; 321(2):255-66. PubMed ID: 24211746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin.
    Massoumi R; Nielsen CK; Azemovic D; Sjölander A
    Exp Cell Res; 2003 Oct; 289(2):342-51. PubMed ID: 14499635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.
    O'Connell MR; Sarkar S; Luthra GK; Okugawa Y; Toiyama Y; Gajjar AH; Qiu S; Goel A; Singh P
    Sci Rep; 2015 Oct; 5():14983. PubMed ID: 26447334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth.
    Phinney BB; Ray AL; Peretti AS; Jerman SJ; Grim C; Pinchuk IV; Beswick EJ
    Front Immunol; 2018; 9():1857. PubMed ID: 30298062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer.
    Hwang WL; Lan HY; Cheng WC; Huang SC; Yang MH
    J Hematol Oncol; 2019 Jan; 12(1):10. PubMed ID: 30683126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
    Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth.
    Tsai FM; Wu CC; Shyu RY; Wang CH; Jiang SY
    J Biomed Sci; 2011 Nov; 18(1):88. PubMed ID: 22126303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells.
    Han H; Xue-Franzén Y; Miao X; Nagy E; Li N; Xu D; Sjöberg J; Björkholm M; Claesson HE
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):122-30. PubMed ID: 26115646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mucociliary clearance of the eustachian tube by leukotrienes C4 and D4.
    Ganbo T; Hisamatsu K; Shimomura S; Nakajima T; Inoue H; Murakami Y
    Ann Otol Rhinol Laryngol; 1995 Mar; 104(3):231-6. PubMed ID: 7872607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo.
    Ruan D; So SP
    Life Sci; 2014 Oct; 116(1):43-50. PubMed ID: 25139833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer.
    Bellamkonda K; Satapathy SR; Douglas D; Chandrashekar N; Selvanesan BC; Liu M; Savari S; Jonsson G; Sjölander A
    Cancer Lett; 2018 Nov; 437():13-24. PubMed ID: 30144515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.